The Jacksonville Jaguars traded up to select WR/CBTravis HunterNo. 2 in the 2025 NFL draft in April. Hunter entered the NFL trying to do what few other have done before him -- play both offense and ...

No additional Democrats broke ranks during Wednesday's votes. The Senate on Wednesday -- the first day of a government shutdown-- once again failed to pass bills aimed at funding the government as ...

Dr. James McCaffrey presents a complete end-to-end demonstration of linear regression with two-way interactions between predictor variables. Standard linear regression predicts a single numeric value ...

Sen. Josh Hawley (R-MO) got into a heated verbal spat with a former Biden official after the congressman demanded to know what a “two spirit individual” is on Tuesday, among other “gobbledegook” ...

The Los Angeles Lakers have signed guard Nick Smith Jr. to a two-way contract. This is the final two-way spot the Lakers had to offer and Smith join Christian Koloko and Chris Manon on two-way deals.

Tropical Storm Humberto is churning over the western Atlantic, about 1,600 miles away from the East Coast of the United States, while a second tropical disturbance roiling near Hispaniola and Puerto ...

It’s week two on Dancing with the Stars, or as host Alfonso Ribeiro proudly reports, “the most watched entertainment show in America!” Hmm, we’ll see if they can sustain that after tonight, especially ...

The 2024-25 Oklahoma City Thunder achieved dominant results by holding opponents to poor shooting from the field. It allowed a 51.3% effective field goal percentage (No. 1 in NBA) during the regular ...

The Brooklyn Nets added another Chinese star to their roster ahead of training camp. Former G League Ignite forward Fanbo Zeng signed an Exhibit 10 contract and will compete for a two-way spot. Zeng ...

The formation of Mercury remains an unsolved mystery. The planet closest to the sun has a disproportionately large metallic core—accounting for about 70% of its mass—and a relatively small rocky ...

On Friday, Skye Bioscience, Inc. (NASDAQ:SKYE) announced the presentation of results from the Phase 1b study of nimacimab in subjects with metabolic-associated steatotic liver disease (MASLD) at the ...